Patent · US Active

Aminopyridine compounds useful as inhibitors of protein prenylation

US10654838B2 · kind B2 · utility

0Cited by
0References
16Claims
0Family size

Assignees

Inventors

Key dates

Filing dateOct 7, 2015
Grant dateMay 19, 2020
Priority date
Expiry dateOct 7, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D405/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A compound for use in the treatment and/or prevention of diseases or disorders wherein an inhibition of protein prenylation is required, which is alternatively chosen among and wherein R5 and R6 represent a hydrogen atom or a (C1-4)alkyl group; and R7 represents an arylcarbonyl group, a heteroarylcarbonyl group, a heteroarylacetyl group, a (C1-C4)alkoxy-carbonylmethyl group, a group. Also disclosed are novel compounds of formulae (I) and (II).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.